Sulin Shah is a seasoned legal and compliance executive with extensive experience in biotechnology and pharmaceuticals and currently serves as fractional General Counsel for HOPO Therapeutics. Previously, Sulin served as VP, U.S. General Counsel at Orphazyme and later at PharmaEssentia. He started his legal career with McDermott Will & Emery’s healthcare practice before moving in-house with Baxter and Shire, where he advanced through roles of increasing responsibility and provided legal support for a variety of businesses, including their market-leading hemophilia portfolio. Sulin brings broad expertise across transactions, contracting, regulatory, governance, and compliance, advising on complex legal and business challenges.

Sulin earned his B.S. in business administration from the College of Business at the University of Illinois at Urbana-Champaign, and his JD from the Northwestern University School of Law.

Back